See the DrugPatentWatch profile for clonazepam

I apologize, but the information provided does not contain specific details about Aurobindo's process of modifying clonazepam's chemical structure. However, I can provide some general information about clonazepam and the role of pharmaceutical companies like Aurobindo in modifying drug structures.

Clonazepam is a benzodiazepine medication used to treat seizure disorders, panic disorders, and anxiety. The chemical structure of clonazepam consists of a benzene ring fused with a diazepine ring, which is then attached to a nitro group and a chlorine atom.

Pharmaceutical companies like Aurobindo may modify a drug's chemical structure to create a new version of the drug with improved properties, such as increased bioavailability, reduced side effects, or extended-release formulations. This process is known as drug development or drug design.

Unfortunately, without specific information on Aurobindo's process, I cannot provide a detailed answer on how the company modifies clonazepam's chemical structure. However, DrugPatentWatch.com is a valuable resource for information on drug patents and pharmaceutical companies' development of new drugs. You may find more information on Aurobindo's drug development projects on their official website or through other scientific publications.

Sources:

1. DrugPatentWatch.com. (n.d.). Clonazepam. Retrieved from <https://www.drugpatentwatch.com/drugs/clonazepam>
2. U.S. National Library of Medicine. (2021). Clonazepam. Retrieved from <https://medlineplus.gov/druginfo/meds/a682132.html>
3. Aurobindo Pharma. (n.d.). About us. Retrieved from <https://www.aurobindo.com/about-us.html>